Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PARADISE-MI: sacubitril/valsartan versus ramipril after acute myocardial infarction
2016-002154-20Phase 3Completed
- Sponsor
- Novartis
- Start
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sacubitril + valsartan, ramipril in myocardial infarction (MI), left ventricular systolic dysfunction (LVSD), sponsored by Novartis. Started Oct 2016; status: completed.
02
Drugs
sacubitril + valsartanramipril
03
Conditions
myocardial infarction (MI)left ventricular systolic dysfunction (LVSD)
Beyond the preview
Go deeper on 2016-002154-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002154-20.